Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
330 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Solaxa Inc.Pharmaceuticals
Bethesda, Maryland · founded 2021 · Equity, Simple Agreement for Future Equity · 1 investors · Lauren Sabella, Christian Walker
OptiNose, Inc.Pharmaceuticals
Yardley, Pennsylvania · Equity · 2 investors · Paul Spence, Catherine Owen
Context Therapeutics Inc.Pharmaceuticals
Philadelphia, Pennsylvania · founded 2021 · Equity, Convertible · 26 investors · Alex Levit, Linda West
Retension Pharmaceuticals, Inc.Pharmaceuticals
Mclean, Virginia · founded 2023 · Equity · 132 investors · Donald Olds, Michael Berendt
Aeovian Pharmaceuticals, Inc.Pharmaceuticals
Berkeley, California · Equity · 5 investors · Davis Ryman, Nils Regge
Endo, Inc.Pharmaceuticals
Malvern, Pennsylvania · founded 2023 · Equity · 404 investors · Scott Hirsch, Paul Efron
Reunion Neuroscience Management, Inc.Pharmaceuticals
Philadelphia, Pennsylvania · founded 2023 · Equity · 9 investors · Robert Alexander, Gregory Mayes
Solaxa Inc.Pharmaceuticals
Bethesda, Maryland · founded 2021 · Equity · 8 investors · Luis Gutierrez, Christian Walker
Lucy Therapeutics, Inc.Pharmaceuticals
Waltham, Massachusetts · Equity, Options · 6 investors · Rachel Sha, Robert Poole
Cristcot LLCPharmaceuticals
Concord, Massachusetts · Convertible, Convertible Debt · 30 investors · James Bartlett, Jennifer Davagian
Acta Pharmaceuticals, Inc.Pharmaceuticals
Boston, Massachusetts · founded 2022 · Equity · 29 investors · George Alex, Thierry Porte
Rallybio CorpPharmaceuticals
New Haven, Connecticut · Equity · 1 investors · Martin Mackay, Paula Soteropoulos
TORL Biotherapeutics LLCPharmaceuticals
Culver City, California · Equity · 52 investors · Mark Alles, Mark Attanasio
Pierrepont Therapeutics, Inc.Pharmaceuticals
Brooklyn, New York · founded 2020 · Debt · 2 investors · Matthew Wyckoff, Peter Barber
Sparrow Pharmaceuticals, Inc.Pharmaceuticals
Portland, Oregon · Debt, Options · 4 investors · Peter Thompson, Jonathan Root
VACCINEX, INC.Pharmaceuticals
Rochester, New York · Equity, Options, Convertible · 1 investors · Chrystyna Bedrij Stecyk, Elizabeth Evans
VACCINEX, INC.Pharmaceuticals
Rochester, New York · Equity, Options, Convertible · 3 investors · Jill Sanchez, Maurice Zauderer, Ph.D.
Melt Pharmaceuticals, Inc.Pharmaceuticals
Brentwood, Tennessee · founded 2019 · Equity · 309 investors · Larry Dillaha, Brad Osborne
Pagari Life Science Corp.Pharmaceuticals
Bethalta, Illinois · founded 2022 · Equity · 2 investors · Marni Zenkewicz, James Wickenhauser
NovaBay Pharmaceuticals, Inc.Pharmaceuticals
Emeryville, California · Debt, Options, Convertible · 5 investors · Yongxiang (Sean) Zheng, Tommy Law
Enliven Therapeutics, Inc.Pharmaceuticals
Boulder, Colorado · Equity, Options, Convertible · 20 investors · Helen Collins, Andrew Phillips
Coeurative, Inc.Pharmaceuticals
Roanoke, Virginia · Equity · 2 investors · John Schmedtje, Jr.
Chrysalis Biotherapeutics, Inc.Pharmaceuticals
Galveston, Texas · Equity, Debt · 12 investors · Lauri Sower, Darrell Carney
NEKTAR THERAPEUTICSPharmaceuticals
San Francisco, California · Equity, Options · 1 investors · Roy Whitfield, Mark Wilson
Mind Medicine (MindMed) Inc.Pharmaceuticals
New York, New York · Equity · 2 investors · David Gryska, Schond Greenway
Immunophotonics, Inc.Pharmaceuticals
St. Louis, Missouri · Debt · 17 investors · Bobby Sandage, Wei Chen
ADIAL PHARMACEUTICALS, INC.Pharmaceuticals
Glen Allen, Virginia · Equity, Options, Convertible · 1 investors · James Newman, Jr., Cary Claiborne
Nocion Therapeutics, Inc.Pharmaceuticals
Watertown, Massachusetts · Equity · 13 investors · Julie Grant, Rosy Hu
Pharmaceutics International, Inc.Pharmaceuticals
Hunt Valley, Maryland · Equity · 6 investors · James Gale, Syed Abidi, Ph.D.
DepYmed Inc.Pharmaceuticals
Farmingdale, New York · Equity · 2 investors · Andreas Grill, Steve Winick